Zobrazeno 1 - 10
of 283
pro vyhledávání: '"E. Terzoli"'
Autor:
C. Campanella, R. Perrone Donnorso, M. Zeuli, E. Terzoli, Barbara Vanni, Carlo Garufi, A. Torsello, Isabella Sperduti, Francesco Cognetti, Maria Grazia Diodoro, Carmen D'Angelo, Maurizio Cosimelli, M. Mottolese
Publikováno v:
European Journal of Cancer. 44:1217-1222
Young people (40 years of age) with colorectal cancer (CRC) represent a distinct subgroup with more aggressive disease behaviour compared to older patients. We evaluate whether p53 and bcl-2 could be useful in identifying young patients at higher ris
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba952c5e5886041dce3fb3eb0c872bef
https://doi.org/10.1016/j.ejca.2008.03.002
https://doi.org/10.1016/j.ejca.2008.03.002
Publikováno v:
Annals of Oncology. 15:1684-1690
Background Once-weekly dosing of recombinant human erythropoietin (rhEPO) in patients with myelodysplastic syndromes (MDS) has not been investigated thoroughly. We performed a clinical trial to evaluate the effects of this new dosing regimen in patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66dc151036e54b12dbca5f42b8506923
https://doi.org/10.1093/annonc/mdh428
https://doi.org/10.1093/annonc/mdh428
Autor:
Andrea Martoni, Mauro Mansutti, E. Terzoli, Giuseppe Capri, C. Sguotti, Giacomo Grasselli, N. Azli, G. Robustelli Della Cuna, Emiliana Tarenzi, Sara Cresta, L. Frevola, A. Jirillo, Luca Gianni, G. Lelli, F. Buzzi, M. Murawsky
Publikováno v:
Annals of Oncology. 15:433-439
Background: This randomized phase II study was conducted to evaluate the efficacy of doxorubicin and docetaxel (DOC) administered either as a combination, an alternating or a sequential regimen in women with metastatic breast cancer. Secondary object
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::237d66f6bf89d06dec67d224dd612478
https://doi.org/10.1093/annonc/mdh107
https://doi.org/10.1093/annonc/mdh107
Publikováno v:
British Journal of Cancer
The combination of irinotecan (CPT-11), oxaliplatin (L-OHP), 5-fluorouracil (5-FU) and folinic acid (FA) is one of the possibilities to overcome chemoresistance in advanced colorectal cancer (ACRC) patients. The aim of this study was to determine the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19d2128b648da65a430d142084a7e903
https://doi.org/10.1038/sj.bjc.6601382
https://doi.org/10.1038/sj.bjc.6601382
Autor:
Elisabeth Filipski, R M D'Attino, Vrignaud P, Francis Lévi, E. Terzoli, Bissery Mc, Teresa G. Granda, Carlo Garufi
Publikováno v:
British Journal of Cancer
The relevance of circadian rhythms in irinotecan and oxaliplatin tolerability was investigated with regard to antitumour activity. Mice bearing Glasgow osteosarcoma (GOS) received single agent irinotecan (50 or 60 mg kg−1 per day) or oxaliplatin (4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ebe7c9c5e44bed070022d5bc3f8de26
https://doi.org/10.1038/sj.bjc.6600168
https://doi.org/10.1038/sj.bjc.6600168
Autor:
Cecilia Nisticò, A.M. D'Ottavio, E. Terzoli, Carlo Garufi, Albina Rita Zappalà, Anna Maria Aschelter, S. Brienza, A. Vaccaro
Publikováno v:
Annals of Oncology. 12:179-182
2Debioclinic, Charenton-Le-Pont. France Summary Purpose: Oxaliplatin (L-OHP), a new platinum analogue, is an active drug in colorectal and ovarian cancer. In this phase II study we explored tolerability and activity of oxaliplatin as a single agent i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8c977afa8b56185e60185bb771a649c
https://doi.org/10.1023/a:1008386419047
https://doi.org/10.1023/a:1008386419047
Combined treatment with thymosin-α1 and low dose interferon-α after dacarbazine in advanced melanoma
Autor:
G. Rasi, E. Terzoli, F. Izzo, P. Pierimarchi, M. Ranuzzi, P. Sinibaldi-Vallebona, C. Tuthill, E. Garaci
Publikováno v:
Melanoma Research. 10:189-192
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9830e1db605e63c4db61b1d2061cdd0
https://doi.org/10.1097/00008390-200010020-00012
https://doi.org/10.1097/00008390-200010020-00012
Autor:
Carlo Garufi, Diana Giannarelli, A.M. D'Ottavio, Sandro Barni, D.A.P. Gallà, Luciano Frontini, A. Vaccaro, E. Terzoli, Cecilia Nisticò
Publikováno v:
Annals of Oncology. 10:937-942
Summary Background This study was designed to explore the effectiveness and tolerability of a weekly regimen of epirubicin and vinorelbine plus granulocyte colony-stimulating factor (G-CSF). Patients and methods Fifty-two patients with previously unt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::061437ec22ac9778046c4e46e41a8944
https://doi.org/10.1023/a:1008324329562
https://doi.org/10.1023/a:1008324329562
Autor:
Paolo Carlini, Francesco Cognetti, Alfredo Falcone, Emilio Bria, Federica Cuppone, Fotios Loupakis, Michele Milella, Cecilia Nisticò, Vanja Vaccaro, E. Terzoli
Publikováno v:
Università di Pisa-IRIS
e15021 Background: The monoclonal antibody against vascular endothelial growth factor BEVA has recently demonstrated to improve survival for MRC patients (pts). Nevertheless, the magnitude of the provided benefit in the daily practice is still contro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01373c773abe23fa7e49aba8f6da1bac
http://hdl.handle.net/11568/130330
http://hdl.handle.net/11568/130330
Autor:
Paola Papaldo, Alessandra Felici, Enzo Maria Ruggeri, Paolo Carlini, Alessandra Fabi, Francesco Cognetti, Diana Giannarelli, Carmen Nuzzo, Gianluigi Ferretti, E. Terzoli, Michele Milella, F.L. Cecere, Emilio Bria, Alain Gelibter, S. Di Cosimo, Mariangela Ciccarese
Publikováno v:
British Journal of Cancer
The purpose of this study was to estimate in all randomised trials the relative risk of overall response rate (ORR), clinical benefit (CB), time to progression (TTP), overall survival (OS), and toxicity of aromatase inhibitors (AI), compared with tam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f584cf705006e8da928dfe328db1767c
http://hdl.handle.net/11573/1348315
http://hdl.handle.net/11573/1348315